WuXi AppTec, WuXi Biologics surge in Hong Kong as biotech firms put some operations for sale
Shares of WuXi AppTec and WuXi Biologics surged in Hong Kong on Friday, following a report that the two firms are looking to divest some of their operations in the wake of new United States legislation targeting Chinese biotech companies. WuXi AppTec’s shares closed up almost 12 per cent to HK$67.10 on Friday, while shares … Read more
